|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
11 April 2016 |
|
Main ID: |
NCT01773200 |
|
Date of registration:
|
18/01/2013 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Prognostic Value of Circulating Endothelial Progenitor Cells in Aneurysmal Subarachnoid Hemorrhage
EVAPROPEC |
|
Scientific title:
|
Prognostic Value of Circulating Endothelial Progenitor Cells in Aneurysmal Subarachnoid Hemorrhage (Evaluation de l'intérêt Pronostic Des progéniteurs endothéliaux Circulants Dans l'hémorragie Sous-arachnoïdienne Par Rupture d'anévrysme cérébral) |
|
Date of first enrolment:
|
March 2013 |
|
Target sample size:
|
92 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT01773200 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Sébastien Pili-Floury, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
CHRU de Besançon |
|
|
Name:
|
Sébastien Pili-Floury, MD, PhD |
|
Address:
|
|
|
Telephone:
|
+33 3 81 66 85 79 |
|
Email:
|
spilifloury@orange.fr |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- recent(< 24 h) aneurysmal subarachnoid hemorrhage
- written informed consent obtained from the patient or from close relatives
Exclusion Criteria:
- refusal to participate
- Non-aneurysmal subarachnoid hemorrhage
- aneurysmal subarachnoid hemorrhage with estimated date of bleeding > 24 h
- Chronic heart failure
- Chronic medication able to modify the plasmatic level of BNP
- Pregnancy
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Aneurysmal Subarachnoid Hemorrhage
|
|
Primary Outcome(s)
|
|
endothelial progenitor cells count
[Time Frame: day 3 after bleeding]
|
|
Secondary Outcome(s)
|
|
Endothelial progenitor cells count
[Time Frame: day 0, 6, 10, 14, 21 after bleeding]
|
|
Plasmatic brain natriuretic peptide
[Time Frame: day 0, 3, 6, 10, 14, 21 after bleeding]
|
|
Maximal amplitude of variation of EPC count
[Time Frame: 3 weeks after bleeding]
|
|
Secondary ID(s)
|
|
P/2012/153
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|